KASEE WIESEN: Open Payments
NPI 1487214664 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 12 payments from 7 companies in 2025. Trend: 2023 $864 · 2024 $445 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Lilly USA, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
Products named: REXULTI, EVENITY, Wegovy, JARDIANCE, Ozempic, VRAYLAR, IBSRELA.
Industry payments across NE — which companies pay providers there.
